Quantcast

Latest Novo Nordisk Stories

2014-02-28 20:23:36

DUBLIN, February 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/xlfhdl/european) has announced the addition of the "Concise Analysis of the European Injectable Drug Delivery - Market Forecasts to 2017" [http://www.researchandmarkets.com/research/xlfhdl/european ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Injectable drug delivery technologies are a combination of two...

2014-02-27 08:30:30

DENVER, February 27, 2014 /PRNewswire/ -- Insulin Pens become smart with IOT "Internet of Things"! Vigilant(TM) unveils Bee+, the first smart insulin injection tracker. Bee+ combines technology and healthcare expertise to improve the lives of people affected by diabetes. A user-friendly electronic cap that fits most insulin pens in the market, Bee+ helps diabetics better manage their injections. Connected by Bluetooth Smart technology to compatible with Apple and...

2014-02-24 08:29:46

SAN DIEGO, Feb. 24, 2014 /PRNewswire/ -- Thesan Pharmaceuticals announced today the closing of a $49M Series B financing, led by Novo Ventures (a current Investor), with SV Life Sciences and Lundbeckfond Ventures joining Novartis Venture Fund in the syndicate. Thesan's mission is the development of novel approaches for the treatment of dermatological disorders, including acne and atopic dermatitis. "Our focus remains the development of new chemical entities with novel mechanisms of...

2014-02-12 12:31:53

LONDON, Feb. 12, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: PharmaPoint: Type 2 Diabetes - Current and Future Players PharmaPoint: Type 2 Diabetes - Current and Future Players Summary GlobalData has released its pharma report, "PharmaPoint: Type 2 Diabetes - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Type 2 Diabetes Market. The report...

2014-02-11 08:32:31

LONDON, Feb. 11, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:China Insulin Delivery Devices Market Outlook and Trends Till 2018 Short DescriptionThis research report provides key market trends, market forecasts and competitive scenario of the insulin delivery devices in China through 2018.The product categories covered in this report include: -- Insulin Pens-- Insulin Syringes-- Insulin Pumps ScopeThe report highlights historic and forecasted...

2014-02-05 08:29:34

FREMONT, Calif., Feb. 5, 2014 /PRNewswire/ -- Zosano Pharma, Inc. (Zosano) announced today that it has entered into an agreement with Novo Nordisk A/S (NYSE: NVO) to develop a new transdermal presentation of semaglutide, an investigational proprietary human GLP-1 (Glucagon-Like Peptide-1) analogue, to be administered once weekly using Zosano's microneedle patch system for the treatment of type 2 diabetes. Initially, Zosano and Novo Nordisk will engage in collaborative efforts to...

2014-01-30 12:28:13

PRINCETON, N.J., Jan. 30, 2014 /PRNewswire/ -- Novo Nordisk (NYSE: NVO), a global healthcare company with 90 years of innovation and leadership in diabetes care, announced the promotion of Eddie Williams to senior vice president of biopharmaceuticals, effective February 1, 2014. (Logo: http://photos.prnewswire.com/prnh/20110414/NY80976LOGO) "Our biopharmaceutical business will be increasingly important to our growth in the U.S. as we apply the protein expertise developed through...

2014-01-23 23:22:31

GIA announces the release of a comprehensive global report on Hormone Replacement Therapy (HRT) markets. Global market for Hormone Replacement Therapy (HRT) is projected to exceed US$3.3 billion by 2020, driven by rising number of women in the menopausal age, and increase in patient awareness levels. San Jose, California (PRWEB) January 23, 2014 Follow us on LinkedIn – Hormone Replacement Therapy refers to use of hormones - estrogens and progestin for alleviating symptoms associated...

2014-01-23 16:24:38

PITTSBURGH, Jan. 23, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Repaglinide Tablets, 0.5 mg, 1 mg and 2 mg. This product is the generic version of Novo Nordisk's Prandin(®), which is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.(1) The company received final approval from the U.S. Food and Drug Administration (FDA) for its...

2014-01-22 12:23:39

LONDON, Jan. 22, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Pharmerging Markets 2012-2016TechNavio's analysts forecast the Pharmerging market to grow at a CAGR of 12.44 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in healthcare spending. The Pharmerging market has also been witnessing an increase in partnerships among vendors. However, the price pressure could pose a challenge to the...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related